Overview: What Is DrChrono?
DrChrono is a cloud-based EHR and practice management platform founded in 2009 with an unusual design choice for its time: it was built iPad-first, treating the tablet as the primary clinical interface rather than an afterthought. That decision turned out to be prescient for mobile clinicians, urgent care, and house-call practices, and DrChrono accumulated a loyal customer base in small-to-mid-size practices that valued being able to chart from anywhere. In 2022, DrChrono was acquired by EverCommerce (NASDAQ: EVCM) and is now part of the EverHealth healthcare software portfolio.
The EverHealth era is the most important context for evaluating DrChrono in 2026. The acquisition has produced both genuine product improvements — notably the launch of EverHealth Scribe, the platform's first native ambient AI documentation tool, in March 2026 — and customer concerns about support quality, product direction, and whether DrChrono will remain a standalone brand or merge into a unified EverHealth suite.
Key Features
- AI-powered cloud-based EHR platform
- EverHealth Scribe ambient documentation (launched March 2026)
- AI no-show predictor with risk scoring
- Customizable medical forms and templates
- Integrated practice management and medical billing
- iPad-first design for mobile clinical workflows
- Patient portal and scheduling
- CarePilot AI partnership for workflow-embedded AI
EverHealth Scribe: The 2026 AI Move
EverHealth Scribe launched in March 2026 as DrChrono's first native ambient AI documentation tool. EverCommerce reports a 32% increase in same-day claim submissions and 8 minutes of documentation time saved per visit in early deployments. These numbers are in line with what mature ambient AI scribes deliver and are a meaningful upgrade for DrChrono customers who previously had to integrate a third-party scribe.
Beyond Scribe, DrChrono has deployed an AI no-show predictor that scores appointment risk to help front-desk staff prioritize confirmation outreach. The CarePilot AI partnership embeds workflow-aware AI into patient encounters, and AI claim scrubbing leverages the EverHealth network's billing data to flag claims likely to be rejected before submission.
Pricing
DrChrono offers four tiers — Prometheus, Hippocrates, Apollo, and Apollo Plus — with per-provider monthly pricing that requires sales engagement to quote. There is no public price list. Apollo Plus add-ons start at $20/provider/month for premium features and advanced reporting.
DrChrono is generally positioned as a more accessible entry point than athenahealth or Epic for new and small practices. For a solo provider opening a new practice, DrChrono is one of the few EHRs that can be operationally live within days of contract signing.
The EverCommerce Concern
We need to address the recurring theme in post-2022 G2 and Capterra reviews: customers report longer support hold times, less knowledgeable first-line support, and concerns about whether DrChrono's product roadmap is being driven by EverCommerce's portfolio strategy rather than clinician needs. EverHealth Scribe is a positive signal, but the support quality concerns are persistent enough that they should factor into a buying decision.
Pros & Cons
Strengths
- ✓ iPad-first design is unmatched for mobile clinicians
- ✓ EverHealth Scribe brings native ambient AI in 2026
- ✓ Fast to deploy for new practices
- ✓ Integrated EHR + practice management + billing
- ✓ Customizable medical forms and templates
Weaknesses
- ✗ Post-EverCommerce acquisition (2022) — growing concerns about product direction and support quality
- ✗ G2 and Capterra reviews cite longer hold times and less knowledgeable support post-acquisition
- ✗ Less mature AI features compared to dedicated AI scribe companies
- ✗ Uncertainty about whether DrChrono will remain standalone or merge into EverHealth suite
- ✗ Smaller market share than Epic, athenahealth, or Oracle Health
- ✗ Limited large health system deployments
Who Should Use DrChrono?
DrChrono is best for new practices needing fast deployment and accessible pricing, mobile clinicians and house-call providers who value the iPad-first design, small-to-mid-size practices wanting integrated EHR + PM + billing, and customers who want to avoid the percentage-of-collections pricing model used by athenahealth.
It is less appropriate for large multi-specialty groups requiring deep customization, hospital settings (DrChrono is not designed for inpatient workflows), or buyers concerned about post-acquisition support quality. For larger ambulatory groups, see athenahealth.
Verdict
DrChrono in 2026 is a competent ambulatory EHR with one genuinely differentiated property — iPad-first design — and a fresh native AI scribe that brings it back into the AI EHR conversation. The EverHealth ownership creates legitimate uncertainty about long-term direction, and we recommend checking current G2 and Capterra reviews before signing a multi-year contract. For mobile clinicians and new practices, it remains a credible choice. For larger groups, athenahealth is the safer option.